Antonio F. Cruz
Chief Executive Officer chez TRANSITION THERAPEUTICS INC
Profil
Antonio F.
Cruz was the founder of Angiotech Pharmaceuticals, Inc. (founded in 1992) where he held the title of Director & Vice President.
He is also the founder of Transition Therapeutics, Inc. (founded in 1998) where he serves as the Chief Executive Officer.
Dr. Cruz currently holds the position of Chairman & Chief Executive Officer at NeuroMedix, Inc. He is also a Director at Treat U SA, Accel-Rx, and Mercal Capital Corp.
(since 2015).
Dr. Cruz has previously served as the President & Chief Executive Officer of the Canadian Arthritis Network.
He has also been a Director at Ellipsis Neurotherapeutics, Inc., BIOTECanada, and Mount Sinai Hospital (Canada) where he held the title of Senior Scientist.
Postes actifs de Antonio F. Cruz
| Sociétés | Poste | Début |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Chief Executive Officer | 06/07/1998 |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Treat U SA
 Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Director/Board Member | - |
Mercal Capital Corp.
 Mercal Capital Corp. Financial ConglomeratesFinance Mercal Capital Corp. is a capital pool company, which engages in the identification and evaluation of potential acquisitions or businesses. The company was founded on August 31, 2015 and is headquartered in Ottawa, Canada. | Director/Board Member | 31/08/2015 |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Anciens postes connus de Antonio F. Cruz
| Sociétés | Poste | Fin |
|---|---|---|
| Canadian Arthritis Network | President | 01/01/2001 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Director/Board Member | - |
Mount Sinai Hospital (Canada)
 Mount Sinai Hospital (Canada) Hospital/Nursing ManagementHealth Services Founded in 1923, Mount Sinai Hospital (Canada) operates a hospital. The private company is based in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Founder | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
Ellipsis Neurotherapeutics, Inc.
 Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Health Technology |
Mount Sinai Hospital (Canada)
Mount Sinai Hospital (Canada) Hospital/Nursing ManagementHealth Services Founded in 1923, Mount Sinai Hospital (Canada) operates a hospital. The private company is based in Toronto, Canada. | Health Services |
| Canadian Arthritis Network | Commercial Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Health Technology |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Finance |
Mercal Capital Corp.
Mercal Capital Corp. Financial ConglomeratesFinance Mercal Capital Corp. is a capital pool company, which engages in the identification and evaluation of potential acquisitions or businesses. The company was founded on August 31, 2015 and is headquartered in Ottawa, Canada. | Finance |
